Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | Chief Operating Officer | June 29, 2018 | July 12, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date June 29, 2018 · Filed July 12, 2018 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 92,910 |
Reported balance
After 2018-06-29 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2018-06-29 · Tax withholding · Disposed 1,729 · Balance 92,910 F1: This amendment is being filed solely to report the withholding of shares by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units. |
| Common StockSEC Table I · non-derivative | Direct | 96,559 |
Reported balance
After 2018-07-02 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2018-07-02 · Exercise / conversion · Acquired 3,649 · Balance 96,559 F2: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions. |
| Common StockSEC Table I · non-derivative | Direct | 115,809 |
Reported balance
After 2018-07-02 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2018-07-02 · Exercise / conversion · Acquired 19,250 · Balance 115,809 F2: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions. |
| Common StockSEC Table I · non-derivative | Direct | 124,809 |
Reported balance
After 2018-07-02 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2018-07-02 · Exercise / conversion · Acquired 9,000 · Balance 124,809 F2: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions. |
| Common StockSEC Table I · non-derivative | Direct | 85,160 |
Reported balance
After 2018-07-02 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2018-07-02 · Sale · Disposed 39,649 · Balance 85,160 F2: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions. |
Filing footnotes · ownership attribution and instrument terms
F1: This amendment is being filed solely to report the withholding of shares by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units.
F2: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · derivative · entry 10 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,938 Underlying: Common Stock · 9,000 shares Expires 2027-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 27, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 19,250 | $0.00 Strike: $5.27 | $0.00 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · derivative · entry 9 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 19,250 shares Expires 2026-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 22, 2017 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,649 | $0.00 Strike: $3.70 | $0.00 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · derivative · entry 8 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,649 shares Expires 2020-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 1, 2011 and 1/48th of the shares subject to the option vested monthly thereafter. The shares were fully vested as of January 1, 2014. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 39,649 | $12.48 | $494,910.71 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 6 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,889 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.68, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 9,000 | $2.30 | $20,700.00 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 5 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 19,250 | $5.27 | $101,447.50 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 4 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 3,649 | $3.70 | $13,501.30 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 3 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2018 Filed Jul 12, 2018 19:23 UTC Amendment | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 39,649 | $12.48 | $494,910.71 |
DisclosureSEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 5 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,160 F2 · balance_after: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions. Read SEC document |
| July 02, 2018 Filed Jul 12, 2018 19:23 UTC Amendment | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 9,000 | $2.30 | $20,700.00 |
DisclosureSEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 4 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions. Read SEC document |
| July 02, 2018 Filed Jul 12, 2018 19:23 UTC Amendment | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 19,250 | $5.27 | $101,447.50 |
DisclosureSEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 3 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions. Read SEC document |
| July 02, 2018 Filed Jul 12, 2018 19:23 UTC Amendment | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 3,649 | $3.70 | $13,501.30 |
DisclosureSEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 2 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $12.24 | $0.00 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · derivative · entry 7 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-06-29 F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 2 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,639 F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 17:43 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,639 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on June 1, 2019 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
| June 29, 2018 Filed Jul 12, 2018 19:23 UTC Amendment | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,729 | $12.24 | $21,162.96 |
DisclosureSEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,910 F1 · kind: This amendment is being filed solely to report the withholding of shares by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 16:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 805 | $6.25 | $5,031.25 |
DisclosureSEC source: 0000899243-18-002273 · doc4.xml · nonDerivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,639 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain restricted stock units. Read SEC document |
| January 22, 2018 Filed Jan 23, 2018 18:51 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,691 | $6.29 | $10,636.39 |
DisclosureSEC source: 0000899243-18-001706 · doc4.xml · nonDerivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,586 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain restricted stock units. Read SEC document |
| January 22, 2018 Filed Jan 25, 2018 19:46 UTC Amendment | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,691 | $6.29 | $10,636.39 |
DisclosureSEC source: 0000899243-18-002029 · doc4a.xml · nonDerivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,444 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain restricted stock units. F2 · balance_after: This amendment is being filed solely to correct the number of non-derivative securities reported on the original Form 4 as beneficially owned by the Reporting Person as of January 22, 2018; 8,858 shares of the Issuer's common stock were inadvertently omitted. Read SEC document |
| January 19, 2018 Filed Jan 25, 2018 19:36 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 8,858 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0000899243-18-002015 · doc4.xml · derivative · entry 2 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,858 Underlying: Common Stock · 8,858 shares Expires 2028-01-19 F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on January 19, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| January 19, 2018 Filed Jan 25, 2018 19:36 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 8,858 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-002015 · doc4.xml · nonDerivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,135 F1 · shares: The reported securities are represented by restricted stock units 1/4th of which shall vest on January 19, 2019 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
| November 30, 2017 Filed Nov 30, 2017 21:23 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,948 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0000899243-17-027731 · doc4.xml · derivative · entry 3 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,948 shares Expires 2018-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option vested monthly over a four year period commencing January 1, 2008 and became fully vested on January 1, 2012. Read SEC document |
| November 30, 2017 Filed Nov 30, 2017 21:23 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 10,948 | $7.17 | $78,487.31 |
DisclosureSEC source: 0000899243-17-027731 · doc4.xml · nonDerivative · entry 2 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,277 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.135 to $7.22, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 30, 2017 Filed Nov 30, 2017 21:23 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 10,948 | $3.36 | $36,785.28 |
DisclosureSEC source: 0000899243-17-027731 · doc4.xml · nonDerivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 16:05 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantOption to Purchase Common Stock · Derivative | 8,906 | Not disclosed Strike: $5.49 | Not disclosed |
DisclosureSEC source: 0000899243-17-026010 · doc4.xml · derivative · entry 2 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,906 Underlying: Common Stock · 8,906 shares Expires 2024-11-09 F3 · security: Represents a stock option granted pursuant to the Exchange Offer (the "New Options"). F4 · derivative.exercise_price: The exercise price per share equals the closing price per share of the Company's common stock, as quoted by NASDAQ, on November 9, 2017. F2 · price: On November 8, 2017, pursuant to the offer by CareDx, Inc. (the "Company") to exchange certain outstanding stock options for new options as more fully described in the Schedule TO-I, filed with the Securities Exchange Commission on October 12, 2017, as amended and supplemented on October 24, 2017 and November 9, 2017(the "Exchange Offer"), the Company cancelled a stock option for 14,597 shares granted to the reporting person on April 8, 2014. In exchange for such cancelled stock option, the reporting person received a new stock option for 8,906 shares. F5 · derivative.exercise_date: The New Options are scheduled to vest in three equal installments based upon the Company's achievement of certain performance goals as follows: (i) one third of the New Options vest upon the Company's determination, which has been reviewed by the Company's independent registered public accounting firm, that the Company has achieved $10 million of total cumulative sales of Allosure, its proprietary next-generation sequencing-based test to detect donor-derived, cell-free DNA after transplantation, commencing after the completion of the Exchange Offer, (ii) one third of the New Options vest upon the Company's determination, which has been reviewed by the Company's independent registered public accounting firm, that the Company has achieved quarterly revenues of at least $18.75 million for two consecutive fiscal quarters commencing after the completion of the Exchange Offer, F6 · derivative.exercise_date: (Continued from Footnote 5) and (iii) one third of the New Options vest in the event the closing sales price of the Company's common stock is at or above $5.00 per share, as quoted by NASDAQ, for 10 consecutive trading days after the completion of the Exchange Offer. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 16:05 UTC | CareDx, Inc. CDNA · Entity 4344 | Disposition to issuerOption to Purchase Common Stock · Derivative | 14,597 | Not disclosed Strike: $12.40 | Not disclosed |
DisclosureSEC source: 0000899243-17-026010 · doc4.xml · derivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,597 shares Expires 2024-04-08 F2 · price: On November 8, 2017, pursuant to the offer by CareDx, Inc. (the "Company") to exchange certain outstanding stock options for new options as more fully described in the Schedule TO-I, filed with the Securities Exchange Commission on October 12, 2017, as amended and supplemented on October 24, 2017 and November 9, 2017(the "Exchange Offer"), the Company cancelled a stock option for 14,597 shares granted to the reporting person on April 8, 2014. In exchange for such cancelled stock option, the reporting person received a new stock option for 8,906 shares. F1 · derivative.exercise_date: 13,077 of the shares underlying the cancelled option were vested and immediately exercisable. The remaining shares underlying the cancelled option were scheduled to vest monthly in increments of 1/48th of the shares subject to the options. Read SEC document |
| September 01, 2017 Filed Sep 5, 2017 18:29 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0000899243-17-021470 · doc4.xml · derivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-09-01 F1 · derivative.exercise_date: 50% of the shares subject to the option shall vest on September 1, 2018 and 1/72nd of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 18:37 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-17-005007 · doc4.xml · derivative · entry 2 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2027-02-17 F3 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on January 27, 2018 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 18:37 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-005007 · doc4.xml · nonDerivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,277 F1 · shares: The reported securities are represented by restricted stock units 1/4th of which shall vest on January 27, 2018 and 1/4th of which shall vest on each yearly anniversary thereafter. F2 · balance_after: Includes 6,000 shares that Reporting Person acquired pursuant to Issuer's 2014 Employee Stock Purchasing Plan; 3,000 shares on June 30, 2015 and 3,000 shares on June 30, 2016. Read SEC document |
| September 26, 2016 Filed Oct 4, 2016 16:55 UTC | CareDx, Inc. CDNA · Entity 4344 | PurchaseCommon Stock | 10,000 | $4.00 | $40,000.00 |
DisclosureSEC source: 0000899243-16-030857 · doc4.xml · nonDerivative · entry 1 Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,277 F1 · balance_after: Includes 3,000 shares that Reporting Person acquired pursuant to Issuer's 2014 Employee Stock Purchase Plan on July 1, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.